New Accelrys Externalized Collaboration Suite Moves Research Networks to the Cloud

Tue Apr 9, 2013 8:00am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130409:nPnMM91011

Proven software solution facilitates technology transfer, collaboration and
scientific informatics in externalized life science partner networks
BOSTON,  April 9, 2013  /PRNewswire/ -- Bio-IT World --  Accelrys, Inc. (NASDAQ:
ACCL), a leading provider of scientific innovation lifecycle management
software, has announced the launch of the  Accelrys Externalized Collaboration
Suite, a software solution designed specifically to address the needs of life
sciences organizations engaged in externalized network research. The suite is
the only offering currently available that addresses the full range of
externalization needs from technology transfer through networked collaboration
to scientific informatics across all research data including experiments,
chemical structures, assays and other test results. The result is a more
holistic externalization strategy for partnering pharmaceutical, contract
research, biotechnology and academic organizations as well as increased
flexibility, reduced complexity and improved operational excellence in
collaborative network research.

To view the multimedia assets associated with this release, please click 
http://www.prnewswire.com/news-releases/new-accelrys-externalized-collaboration-suite-moves-research-networks-to-the-cloud-202038841.html

"Today most life sciences companies are grappling with informatics challenges
surrounding externalization," said Accelrys president and chief executive
officer  Max Carnecchia. "Recognizing that consistent, repeatable scientific
innovation is increasingly driven by global networks of contract research
providers today, Accelrys has made externalized research a strategic part of
product direction and a clear focus of investment to meet our customers' ongoing
research informatics needs."  

"With the pharmaceutical industry rapidly moving to multi-partner research
collaborations to innovate faster and lower research and development costs, the
operational processes typically in place today - a patchwork of email exchanges,
E-rooms, SharePoint portals and VPNs - simply do not work well," said Dr.  Matt
Hahn, senior vice president and chief technology officer at Accelrys. "The
Accelrys Externalized Collaboration Suite meets the challenges of this new
working environment by enabling intelligent, real-time routing of work and
seamless, compliant data transfer in the cloud across externalized research
networks."

The Accelrys Externalized Collaboration Suite enables secure, real-time,
cloud-based access to results within research networks by both sponsor and
partner organizations, enabling them to advance their parts of shared projects
with maximum efficiency and speed.  The Suite consists of:

* Accelrys HEOSĀ®  - A SaaS-based information management and collaboration
workspace enabling secure, real-time transfer of structured project data among
multiple partners; enforcement of sponsor business rules on results posted by
network partners; and IP storage in a secure, project-specific information
warehouse.  
* Contur ELN  - A flexible, multi-disciplinary, low-cost-of-ownership electronic
lab notebook that improves information sharing and reuse, data protection,
process documentation and overall productivity. The Contur ELN can be deployed
through a Cloud-based subscription to support technology transfer of
experimental methods and requests from sponsors to CROs/network partners and CRO
compliance with sponsor requirements for secure, auditable documentation of
experiments.  
* Accelrys Enterprise Platform  - A scientifically aware information integration
and analytics platform facilitating the exchange and management of information
created in-house and within externalized partner networks and transforming the
data where necessary. The platform also supports the extensibility of cloud
systems to implement standard business rules and data analysis methods ensuring
results data is compliant with the informatics standards of sponsoring
organizations.

Accelrys is uniquely qualified in the research informatics market given its
proven track record of  more than nine years delivering successful cloud
offerings including hosted content in DiscoveryGate with tens of thousands of
users and millions of data points, and Accelrys HEOS with more than 70
organizations collaborating in large research networks. Accelrys also offers
depth of experience in scientific research; a breadth of scientific solutions
delivering demonstrated technology transfer, externalization/collaboration and
scientific informatics capabilities; a long-term vision of the solutions needed
to address externalization challenges; and a strong track record partnering with
customers to leverage the "new frontier" of externalized research.

To learn more about the  Accelrys Externalized Collaboration Suite, visit
Accelrys at booth #301 at Bio-IT World. To learn more about today's externalized
life science partner networks, download the Technology Spotlight whitepaper
"Embracing a Collaboration Network Model for Discovery Research" (April 2013)
produced by IDC Health Insights.   

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation
lifecycle management software, supports industries and organizations that rely
on scientific innovation to differentiate themselves. The industry-leading
Accelrys Enterprise Platform provides a broad and flexible scientific solution
optimized to integrate the diversity of science, experimental processes and
information requirements across the research, development, process scale-up and
early manufacturing phases of product development. By incorporating capabilities
in applications for modeling and simulation, enterprise lab management, workflow
and automation, and data management and informatics, Accelrys enables scientific
innovators to access, organize, analyze and share data in unprecedented ways,
ultimately enhancing innovation, improving productivity and compliance, reducing
costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical,
biotechnology, energy, chemicals, aerospace, consumer packaged goods and
industrial products industries. Headquartered in  San Diego, California, USA,
Accelrys employs more than 200 full-time Ph.D. scientists. For more information
about Accelrys, visit  www.accelrys.com.  

Related Links

Accelrys Externalized Collaboration Suite 
Infographic: A quick overview of the externalized research challenge and
solution 
Video: Externalization is Forcing Change in IT Infrastructures 
Webinar Series: Register for informative, live webinars on externalized
collaboration 
Whitepaper: Embracing a Collaboration Network Model for Discovery Research 
Accelrys Website 
Follow Accelrys on Twitter 
Friend Accelrys on Facebook 
Connect with Accelrys on LinkedIn 
Accelrys' YouTube Channel

SOURCE  Accelrys, Inc.


Racepoint Group, Susan Thomas, 415-694-6728 / 619-540-9195,
sthomas@racepointgroup.com

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.